Immuron (IMRN) Other Operating Expenses (2016 - 2024)
Immuron (IMRN) recorded quarterly Other Operating Expenses of $374.2 billion in Q4 2024, up 15054537.87% quarter-over-quarter from $2.5 million in Q4 2023, and up 15054537.87% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) Other Operating Expenses (2016 - 2024) Analysis & Trends
Immuron's Other Operating Expenses history runs 9 years deep, the most recent figure standing at $374.2 billion for Q4 2024.
- In Q4 2024, Other Operating Expenses rose 15054537.87% year-over-year to $374.2 billion; the TTM figure through Sep 2025 stood at $374.2 billion (up 15054537.87% YoY), while the FY2025 annual figure was $19775.7, up 91.33% from the prior year.
- Other Operating Expenses was $374.2 billion for Q4 2024 at Immuron, up from $2.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $374.2 billion in Q4 2024 to a low of $3154.6 in Q4 2021.
- Historically, Other Operating Expenses has averaged $74.8 billion across 5 years, with a median of $1.6 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Other Operating Expenses fell 7.34% in 2021, then soared 15054537.87% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at $3404.5 in 2020, then dropped by 7.34% to $3154.6 in 2021, then surged by 50907.73% to $1.6 million in 2022, then jumped by 54.46% to $2.5 million in 2023, then jumped by 15054537.87% to $374.2 billion in 2024.
- The last three Other Operating Expenses figures came in at $374.2 billion (Q4 2024), $2.5 million (Q4 2023), and $1.6 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 374.16 Bn |
| Dec 31, 2023 | 2.49 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 3,154.63 |
| Dec 31, 2020 | 3,404.49 |
| Dec 31, 2019 | 2,955.04 |
| Dec 31, 2018 | 310,397.00 |
| Dec 31, 2017 | 1.08 Mn |
| Dec 31, 2016 | 615,948.78 |
| Jun 30, 2016 | 2.25 Mn |